D64.81Billable
Anemia due to antineoplastic chemotherapy
- Chapter
- 3. Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Category
- D64
- Effective date
- October 1, 2026
Related codes in category D64
D64Other anemiasD64.0Hereditary sideroblastic anemiaYesD64.1Secondary sideroblastic anemia due to diseaseYesD64.2Secondary sideroblastic anemia due to drugs and toxinsYesD64.3Other sideroblastic anemiasYesD64.4Congenital dyserythropoietic anemiaYesD64.8Other specified anemiasD64.89Other specified anemiasYesD64.9Anemia, unspecifiedYes
Frequently asked questions
What is ICD-10 code D64.81?
D64.81 is an ICD-10-CM diagnosis code for Anemia due to antineoplastic chemotherapy.
Is D64.81 a billable code?
Yes. D64.81 is billable and specific enough to be used on a claim.
What ICD-10-CM chapter is D64.81 in?
D64.81 falls under Chapter 3: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism.
When did D64.81 become effective?
D64.81 has been effective since October 1, 2026, per the CMS/CDC ICD-10-CM annual release.
What other codes are related to D64.81?
D64.81 belongs to category D64, which includes 9 other codes — see the related codes list on this page.
ICD-10-CM data maintained by CDC/CMS (public domain). Always verify codes with authoritative sources before making coding or billing decisions.